SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-21-065216
Filing Date
2021-05-12
Accepted
2021-05-12 17:12:16
Documents
5
Effectiveness Date
2021-05-12

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2115585d1_s8.htm S-8 59081
2 EXHIBIT 5.1 tm2115585d1_ex5-1.htm EX-5.1 23560
3 EXHIBIT 23.1 tm2115585d1_ex23-1.htm EX-23.1 2861
4 GRAPHIC tm2115585d1_ex5-1img001.jpg GRAPHIC 7430
5 GRAPHIC tm2115585d1_ex5-1img002.jpg GRAPHIC 7513
  Complete submission text file 0001104659-21-065216.txt   107386
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-256045 | Film No.: 21916118
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences